🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study has 2 parts: a Dose Escalation Part and a Dose Expansion Part. ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-10
Trial ID
NCT03283046
Treatments Being Tested
Establishment of safety profile of HuMax-CD38 when given as monotherapy in ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03-26
Trial ID
NCT00574288
Treatments Being Tested
The purpose of this study is to investigate the efficacy and safety of long...
Status
Completed
Location
Kameda Medical Center
Start Date
2018-02-18
Trial ID
NCT03416374
Treatments Being Tested
Study Objectives 1. Evaluate the efficacy of the combination of thalidomid...
Status
Completed
Location
Weill Medical College of Cornell University
Start Date
2007-10
Trial ID
NCT00538733
Treatments Being Tested
The purpose of this study is to compare a standard chemotherapy regimen of ...
Status
Unknown
Location
112 sites UK wide
Start Date
2010-05
Trial ID
NCT01554852
Treatments Being Tested
A phase 3, randomized, open-label, parallel-controlled, multi-center study ...
Status
Completed
Location
Capital Medical University (CMU) - Beijing Chao-Yang Hospital
Start Date
2019-03-27
Trial ID
NCT03952091
Treatments Being Tested
This study is being done to determine the efficacies of two preventative dr...
Status
Completed
Location
The Ohio State University Wexner Medical Center
Start Date
2007-06
Trial ID
NCT01474915
Treatments Being Tested
This protocol is an international, multicenter, comparative, open and rando...
Status
Unknown
Location
Hospital Universitário Clementino Fraga Filho
Start Date
2007-01
Trial ID
NCT01532856
This is an open label, multicenter, dose escalation, phase Ib study to dete...
Status
Completed
Location
Institut Jules Bordet
Start Date
2016-10
Trial ID
NCT02741388
Treatments Being Tested
Eligible participants with newly diagnosed myeloma who are not considered e...
Status
Recruiting
Location
Gundersen Lutheran
Start Date
2026-09
Trial ID
NCT07285239